IL22 and graft versus host disease: Consistently, our recent study found that the expansion of IL-22-producing allogeneic T cells was associated with the pathogenesis of SR-Gut-aGVHD in our experimental mouse model, and the elevated IL-22 level led to dysbiosis and further augmented Gut-GVHD (46).